Square Pharmaceuticals PLC. reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported sales was BDT 21,613.45 million compared to BDT 18,813.28 million a year ago.

Revenue was BDT 18,459.2 million compared to BDT 16,069.63 million a year ago. Net income was BDT 6,000.38 million compared to BDT 5,500.32 million a year ago. Basic earnings per share from continuing operations was BDT 6.77 compared to BDT 6.2 a year ago.